MedTech Hub development in India accelerates as a new policy framework and global partnerships reshape the country’s medical technology sector
Biocon has secured a major regulatory milestone with Health Canada's approval for its Autoinjector Pen version of Yesintek. The approval strengthens the company's biosimilar portfolio in North America.
Military medicine now drives a transformative shift in Indian healthcare. India launches its first dedicated academic and operational department for this critical domain
Hyderabad strengthens its healthcare landscape with a dedicated centre focused on diabetic wound care, advanced wound healing, and limb salvage
MedTech Innovation is accelerating in India as Tata Elxsi partners with Sree Chitra Tirunal Institute for Medical Sciences and Technology
The Top News from the pharmaceutical sector this week reflects a rapidly evolving landscape driven by innovation, regulation, and global health priorities
India is strengthening its healthcare ecosystem through new institutional collaborations to accelerate Medical Research in India, with a clear focus on improving patient-centric outcomes through data-backed and evidence-based practices
Cipla has reported its highest-ever quarterly sales record in India, marking a strong start to Q1 FY27. The company's domestic business grew 12 percent year-on-year and became the biggest growth driver. Cipla also delivered steady gains across globa
Dr. Singh shares how Indian pharmaceutical companies can navigate stricter global regulations, foster sustainable quality, embrace digital transformation, and strengthen their position in the global pharmaceutical market.
GSK has received Early FDA Approval for its new lung cancer drug, Jideytro. The decision marks a major milestone for the company as it enters the competitive market for targeted lung cancer therapies.
, CDSCO.jpg)